Susquehanna International Group’s Benitec Biopharma BNTC Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $207K | Sell |
17,728
-208,368
| -92% | -$2.44M | ﹤0.01% | 5505 |
|
2025
Q1 | $2.94M | Buy |
226,096
+201,324
| +813% | +$2.62M | ﹤0.01% | 1798 |
|
2024
Q4 | $313K | Buy |
+24,772
| New | +$313K | ﹤0.01% | 4711 |
|
2022
Q3 | – | Sell |
-3,170
| Closed | -$62K | – | 6148 |
|
2022
Q2 | $62K | Buy |
+3,170
| New | +$62K | ﹤0.01% | 5182 |
|
2019
Q3 | – | Sell |
-291
| Closed | -$55K | – | 4456 |
|
2019
Q2 | $55K | Buy |
291
+12
| +4% | +$2.27K | ﹤0.01% | 4254 |
|
2019
Q1 | $135K | Buy |
279
+53
| +23% | +$25.6K | ﹤0.01% | 2626 |
|
2018
Q4 | $87K | Buy |
226
+91
| +67% | +$35K | ﹤0.01% | 3226 |
|
2018
Q3 | $84K | Sell |
135
-135
| -50% | -$84K | ﹤0.01% | 2977 |
|
2018
Q2 | $137K | Buy |
270
+50
| +23% | +$25.4K | ﹤0.01% | 3222 |
|
2018
Q1 | $166K | Buy |
220
+143
| +186% | +$108K | ﹤0.01% | 2894 |
|
2017
Q4 | $58K | Buy |
+77
| New | +$58K | ﹤0.01% | 3415 |
|